Egger M, Smith G D, Imhoof H, Teuscher A
Department of Medicine, University of Berne, Switzerland.
BMJ. 1991 Sep 14;303(6803):617-21. doi: 10.1136/bmj.303.6803.617.
To examine whether transfer from animal insulin to human insulin is associated with an increased risk of severe hypoglycaemia.
Matched case-control study of insulin treated diabetic patients admitted to hospital because of hypoglycaemia during 1984-7, the period when human insulin was introduced into treatment.
Case admissions and control admissions were obtained from eight public hospitals within the Swiss canton of Berne and a second control group comprised members of the Bernese section of the Swiss Diabetes Association.
94 patients with insulin treated diabetes with a total of 112 admissions for hypoglycaemia during 1984-7 (case admissions), 182 patients with insulin treated diabetes seen in the same hospitals for reasons other than hypoglycaemia with a total of 225 admissions (control admissions), and 86 insulin treated diabetic patients who were members of the Bernese section of the Swiss Diabetes Association.
Type of insulin used at time of admission, glycaemic control as measured by amount of glycated haemoglobin or glucose concentration; severity of hypoglycaemia.
Treatment with human insulin at admission was more common in cases than controls (52/112 (46%) admissions v 77/225 (34%); p = 0.003). 116 out of 129 (90%) of admissions taking human insulin had been transferred from animal insulin, mainly because of non-availability of porcine insulins. The ratio of rate of hypoglycaemia in those taking human insulin to the rate in those taking animal insulin was 2.4 (95% confidence interval 1.3 to 4.4). Other risk factors for hypoglycaemia were a history of hypoglycaemic coma (rate ratio of history to no history 3.8, 2.3 to 6.4) and good glycaemic control (rate ratio of good to poor control 3.9, 1.4 to 7.5). With multivariate analysis the increase in rate ratio associated with use of human insulin rose to 3.0 (1.4 to 6.4). Comparison with the diabetes association controls also showed an increased risk associated with use of human insulin (2.2; 1.1 to 4.8).
Transfer of treatment from animal insulin to human insulin was associated with an increased risk of severe hypoglycaemia. Caution should be exercised when transferring diabetic patients to human insulin. Further studies are required to elucidate why this effect occurs.
探讨从动物胰岛素转换为人类胰岛素是否与严重低血糖风险增加相关。
对1984 - 197年因低血糖入院的接受胰岛素治疗的糖尿病患者进行配对病例对照研究,此期间人类胰岛素开始用于治疗。
病例组和对照组的入院病例来自瑞士伯尔尼州的八家公立医院,第二个对照组由瑞士糖尿病协会伯尔尼分会成员组成。
94例接受胰岛素治疗的糖尿病患者,在1984 - 197年期间因低血糖共入院112次(病例组入院);182例接受胰岛素治疗的糖尿病患者,因非低血糖原因在同一家医院共入院225次(对照组入院);以及86例为瑞士糖尿病协会伯尔尼分会成员的接受胰岛素治疗的糖尿病患者。
入院时使用的胰岛素类型、通过糖化血红蛋白量或血糖浓度衡量的血糖控制情况;低血糖的严重程度。
入院时使用人类胰岛素的情况在病例组中比对照组更常见(112次入院中有52次(46%)使用人类胰岛素,225次入院中有77次(34%)使用;p = 0.003)。在129例使用人类胰岛素的入院病例中,有116例(90%)是从动物胰岛素转换而来,主要原因是猪胰岛素供应不足。使用人类胰岛素者的低血糖发生率与使用动物胰岛素者的低血糖发生率之比为2.4(95%置信区间1.3至4.4)。低血糖的其他危险因素包括有低血糖昏迷病史(有病史与无病史的发生率之比为3.8,2.3至6.4)和良好的血糖控制(良好控制与控制不佳的发生率之比为3.9,1.4至7.5)。多因素分析显示,与使用人类胰岛素相关的发生率比值增加至3.0(1.4至6.4)。与糖尿病协会对照组的比较也显示,使用人类胰岛素与风险增加相关(2.2;1.1至4.8)。
从动物胰岛素转换为人类胰岛素治疗与严重低血糖风险增加相关。将糖尿病患者转换为使用人类胰岛素时应谨慎。需要进一步研究以阐明为何会出现这种效应。